138 related articles for article (PubMed ID: 21904866)
1. Comparative fibril formation of analogs corresponding to the (12-24) segment of the β-amyloid peptide.
Malavolta L; Nakaie CR
Neurol Sci; 2011 Dec; 32(6):1123-7. PubMed ID: 21904866
[TBL] [Abstract][Full Text] [Related]
2. Laminin blocks the assembly of wild-type A beta and the Dutch variant peptide into Alzheimer's fibrils.
Bronfman FC; Alvarez A; Morgan C; Inestrosa NC
Amyloid; 1998 Mar; 5(1):16-23. PubMed ID: 9547001
[TBL] [Abstract][Full Text] [Related]
3. Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein.
Watson DJ; Selkoe DJ; Teplow DB
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):703-9. PubMed ID: 10359654
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril.
Konno T
Biochemistry; 2001 Feb; 40(7):2148-54. PubMed ID: 11329283
[TBL] [Abstract][Full Text] [Related]
5. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease.
Hou L; Kang I; Marchant RE; Zagorski MG
J Biol Chem; 2002 Oct; 277(43):40173-6. PubMed ID: 12198111
[TBL] [Abstract][Full Text] [Related]
6. Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide.
Shen CL; Scott GL; Merchant F; Murphy RM
Biophys J; 1993 Dec; 65(6):2383-95. PubMed ID: 8312477
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
9. Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR.
Balbach JJ; Ishii Y; Antzutkin ON; Leapman RD; Rizzo NW; Dyda F; Reed J; Tycko R
Biochemistry; 2000 Nov; 39(45):13748-59. PubMed ID: 11076514
[TBL] [Abstract][Full Text] [Related]
10. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
Benseny-Cases N; Klementieva O; Cladera J
Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
[TBL] [Abstract][Full Text] [Related]
11. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation.
Soto C; Castaño EM; Frangione B; Inestrosa NC
J Biol Chem; 1995 Feb; 270(7):3063-7. PubMed ID: 7852387
[TBL] [Abstract][Full Text] [Related]
12. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid.
Huang TH; Yang DS; Fraser PE; Chakrabartty A
J Biol Chem; 2000 Nov; 275(46):36436-40. PubMed ID: 10961999
[TBL] [Abstract][Full Text] [Related]
13. Aβ
Anand BG; Prajapati KP; Kar K
Biochem Biophys Res Commun; 2018 Jun; 501(1):158-164. PubMed ID: 29723530
[TBL] [Abstract][Full Text] [Related]
14. Racemization: its biological significance on neuropathogenesis of Alzheimer's disease.
Mori H; Ishii K; Tomiyama T; Furiya Y; Sahara N; Asano S; Endo N; Shirasawa T; Takio K
Tohoku J Exp Med; 1994 Nov; 174(3):251-62. PubMed ID: 7761990
[TBL] [Abstract][Full Text] [Related]
15. A conformation change in the carboxyl terminus of Alzheimer's Abeta (1-40) accompanies the transition from dimer to fibril as revealed by fluorescence quenching analysis.
Garzon-Rodriguez W; Vega A; Sepulveda-Becerra M; Milton S; Johnson DA; Yatsimirsky AK; Glabe CG
J Biol Chem; 2000 Jul; 275(30):22645-9. PubMed ID: 10806193
[TBL] [Abstract][Full Text] [Related]
16. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
[TBL] [Abstract][Full Text] [Related]
17. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
Kaneko I; Morimoto K; Kubo T
Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide.
Sheikh AM; Nagai A
FEBS J; 2011 Feb; 278(4):634-42. PubMed ID: 21205198
[TBL] [Abstract][Full Text] [Related]
19. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism.
Esler WP; Stimson ER; Jennings JM; Vinters HV; Ghilardi JR; Lee JP; Mantyh PW; Maggio JE
Biochemistry; 2000 May; 39(21):6288-95. PubMed ID: 10828941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
